• Jennifer Jarrett notified Arcus that she will resign as Chief Operating Officer, effective March 30, 2026.
• Her departure was described as not resulting from any disagreement regarding the company’s operations, policies, or practices.
• A separation agreement provides that Jarrett will be available for periodic advisory services through June 30, 2026.
• The agreement extends her post-termination exercise period for vested options to 12 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcus Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001724521-26-000014), on March 23, 2026, and is solely responsible for the information contained therein.